Preferred Label : betamethasone dipropionate, calcipotriol drug combination;

Obsolete resource : false;

MeSH note : consists of calcipotriol and betamethasone dipropionate; used to treat psoriasis;

CISMeF synonym : taclonex;

MeSH hyponym : Dovobet; Daivobet;

Is substance : O;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3488641/fr/closalis-calcipotriol/betamethasone-psoriasis
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
betamethasone dipropionate, calcipotriol drug combination
calcipotriene
betamethasone-17,21-dipropionate
adult
calcipotriol, combinations
administration, cutaneous
ointments
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug)
evaluation of the transparency committee
psoriasis

---
https://www.has-sante.fr/jcms/p_3389403/fr/wynzora-calcipotriol/betamethasone-psoriasis
2022
false
false
false
France
drug combinations
treatment outcome
insurance, health, reimbursement
ointments
administration, cutaneous
calcipotriene
betamethasone dipropionate, calcipotriol drug combination
betamethasone
betamethasone-17,21-dipropionate
anti-inflammatory agents
calcipotriol, combinations
dermatologic agents
scalp dermatoses
Psoriasis of scalp (disorder)
Product containing only betamethasone and calcipotriol in cutaneous dose form (medicinal product form)
adult
evaluation of the transparency committee
psoriasis

---
https://www.has-sante.fr/jcms/p_3262265
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
betamethasone dipropionate, calcipotriol drug combination
betamethasone-17,21-dipropionate
administration, cutaneous
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3111988/fr/daivobet-xamiol
2019
false
false
false
France
drug combinations
betamethasone dipropionate, calcipotriol drug combination
insurance, health, reimbursement
evaluation of the transparency committee
betamethasone
betamethasone
calcitriol
calcitriol
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2803498/fr/enstilar
2017
false
false
false
false
France
French
evaluation of the transparency committee
calcipotriol, combinations
treatment outcome
insurance, health, reimbursement
administration, cutaneous
drug combinations
psoriasis
betamethasone dipropionate, calcipotriol drug combination
calcipotriene
betamethasone-17,21-dipropionate
guidelines for drug use
dermatologic agents
anti-inflammatory agents
glucocorticoids
Topical Foam Dosage Form
adult
betamethasone
calcitriol
calcitriol
calcitriol
betamethasone
betamethasone

---
http://www.has-sante.fr/portail/jcms/c_2040751/fr/daivobet
2015
true
France
French
betamethasone dipropionate, calcipotriol drug combination
administration, topical
drug combinations
psoriasis
calcipotriol, combinations
calcipotriene
betamethasone
calcitriol
betamethasone-17,21-dipropionate
insurance, health, reimbursement
scalp dermatoses
administration, cutaneous
adult
treatment outcome
gels
evaluation of the transparency committee
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_1743048/fr/daivobet
http://www.has-sante.fr/portail/jcms/c_968478/daivobet
2014
false
France
French
betamethasone dipropionate, calcipotriol drug combination
administration, topical
drug combinations
psoriasis
calcipotriol, combinations
calcipotriene
betamethasone
calcitriol
betamethasone-17,21-dipropionate
insurance, health, reimbursement
scalp dermatoses
administration, cutaneous
adult
treatment outcome
gels
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_1743051/fr/xamiol
http://www.has-sante.fr/portail/jcms/c_778871/xamiol
2014
false
false
false
France
French
evaluation of the transparency committee
calcipotriol, combinations
administration, topical
insurance, health, reimbursement
treatment outcome
betamethasone dipropionate, calcipotriol drug combination
calcipotriene
betamethasone-17,21-dipropionate
psoriasis
scalp dermatoses
adult
meta-analysis as topic
glucocorticoids
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
betamethasone
betamethasone
calcitriol
calcitriol
drug combinations

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62362440
2012
France
summary of product characteristics
package leaflet
betamethasone
gels
betamethasone dipropionate, calcipotriol drug combination

---
http://www.has-sante.fr/portail/jcms/c_819524/xamiol-calcipotriol-et-betamethasone-en-application-locale
http://www.has-sante.fr/portail/jcms/c_779196/xamiol-ct-6219
2009
France
French
betamethasone dipropionate, calcipotriol drug combination
calcitriol
drug combinations
betamethasone
psoriasis
scalp dermatoses
calcipotriene
betamethasone-17,21-dipropionate
calcipotriol, combinations
evaluation of the transparency committee
guidelines for drug use

---
https://rmlg.uliege.be/article/1380
2006
Belgium
French
psoriasis
betamethasone dipropionate, calcipotriol drug combination
drug combinations
betamethasone
calcitriol
Evidence-Based medicine
administration, cutaneous
treatment outcome
randomized controlled trials as topic
betamethasone dipropionate, calcipotriol drug combination
drug administration schedule
calcipotriene
calcipotriol, combinations
drug information
journal article

---
https://rmlg.uliege.be/article/1340
2005
Belgium
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
betamethasone dipropionate, calcipotriol drug combination
calcipotriene
psoriasis
administration, topical
glucocorticoids
anti-inflammatory agents
betamethasone
calcitriol
dermatologic agents
drug combinations
calcipotriol, combinations
journal article
drug information

---
Nous contacter.
24/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.